Frequency Therapeutics logo

Frequency Therapeutics

Frequency Therapeutics is a small molecules that activate progenitor cells founded in 2015 by David L. Lucchino.

5

Funding Rounds

$220.3m

Money raised

Overview

Frequency Therapeutics is a small molecules that activate progenitor cells founded in 2015 by David L. Lucchino.

Funding series

Funding Series Analysis

The company Frequency Therapeutics has raised a total of $42m in funding over 5 rounds.

Key Insights:

  • Frequency Therapeutics Series B round, January 2019: $42m
  • Frequency Therapeutics, Inc. funding round, July 2020: $42.3m
  • Frequency Therapeutics funding round, July 2019: $62m
  • Frequency Therapeutics funding round, January 2019: $42m
  • Frequency Therapeutics funding round, April 2017: $32m
Frequency Therapeutics logo
Frequency Therapeutics Series B round, January 2019 $42m
Frequency Therapeutics logo
Frequency Therapeutics, Inc. funding round, July 2020 $42.3m
Frequency Therapeutics logo
Frequency Therapeutics funding round, July 2019 $62m
Frequency Therapeutics logo
Frequency Therapeutics funding round, January 2019 $42m
Frequency Therapeutics logo
Frequency Therapeutics funding round, April 2017 $32m

Industries

Frequency Therapeutics is active in the following industries:
  • Regenerative medicine
  • Stem cell technology
  • Immunotherapy
  • Biomedical engineering
  • Technology
  • Healthcare
  • Life science
  • Engineering
  • Synthetic chemistry
  • Biotechnology
  • Biology